drug · small molecule
melphalan hydrochloride
Marketedupdated 5mo agoby $DCTH DELCATH SYSTEMS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 investigational indications.
indications
investigational
Melanoma
all catalysts(0)
nothing on the calendar yet
Trials studying melphalan hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 14, 2030
~3.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (11)
- Jun 29, 2036formulationUS 10537520
- Sep 17, 2034formulationUS 9707331
- Feb 7, 2034formulationUS 9314561
- Jan 16, 2033formulationUS 10195334
- Dec 30, 2032formulationUS 11083831
- Dec 30, 2032formulationUS 11833286
- Nov 7, 2032formulationUS 10098997
- Nov 7, 2032formulationUS 10369264
- Nov 7, 2032method-of-use (U-3683)US 10569004
- Nov 7, 2032formulationUS 11241522
- Nov 7, 2032method-of-use (U-3675)US 11633528
FDA exclusivities (2)
- Aug 14, 2030ODE-438Orphan Drug (7y)3.9y
- Aug 14, 2026NPNP
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that